A Wave of Leadership Turnover Reshapes Health Systems, Insurers and Regulators Heading Into 2027

When a hospital CEO retires or an insurer names a new president, it's easy to treat it as inside baseball, a story for trade publications and investors. But these transitions ripple outward. The people sitting in these chairs decide how hospitals staff their floors, how insurers price premiums, and how fast new technologies like AI actually reach patients. This week's slate of healthcare leadership changes, spanning hospital systems, insurers, pharmacy benefit managers and accrediting bodies, offers a useful snapshot of where the industry is headed, and who will be steering it.

Start with the hospitals, because that's where most people actually experience the healthcare system. Inspira Health in South Jersey announced that CEO Amy Mansue will retire at the end of the year after six years leading the four-hospital system. She's credited with expanding local care access and building a culture of wellness among the system's 7,800 employees, no small feat in an industry still grappling with burnout. Her successor, current President and COO Warren Moore, has three and a half decades of experience and will immediately take on opening a new hospital tower and finishing the system's Epic electronic health record rollout. Think of it like handing off a marathon mid-stride: Moore isn't starting from scratch, he's picking up momentum already in motion.

Similar handoffs are happening at Beth Israel Lahey Health, where Peter Shorett will take over as president and CEO this January, succeeding Kevin Tabb, who has led the Massachusetts system since 2011 and guided it through its 2019 merger with Lahey Health. Shorett helped broker the system's upcoming cancer care collaboration between Beth Israel Deaconess Medical Center and Dana-Farber Cancer Institute, a partnership that matters directly to cancer patients navigating treatment across institutions. Pennsylvania's WellSpan, a 12-hospital, $4.7 billion nonprofit, has tapped Laureen Driscoll, currently a Providence executive overseeing 17 hospitals and $10.3 billion in revenue, to replace the retiring Roxanna Gapstur starting January 4, 2027. Driscoll is a registered nurse by training, a detail worth noting given how often clinical backgrounds get sidelined in executive suites.

Hackensack Meridian Health's Robert Garrett will step down next June after more than four decades with the organization, including the pivotal 2016 merger that created New Jersey's largest health system. Garrett will stay on as CEO emeritus for a transition year, and the board plans to name a successor before year's end. Keck Medicine of USC is also in flux, with CEO Rodney Hanners departing September 24 after six years that extended the system's footprint into Pasadena and the San Gabriel Valley, to be replaced by Steven Shapiro, a former University of Pittsburgh Medical Center president.

Regulators and Insurers Recalibrate

The Joint Commission, which accredits hospitals nationwide, is undergoing its own transition. Jonathan Perlin will retire as president and CEO on December 31 after five years at the helm, a tenure marked by trimming more than 700 hospital standards deemed burdensome or obsolete. That kind of regulatory pruning matters because excessive paperwork and redundant compliance checks can pull clinical staff away from patient care. Perlin will stay on as president emeritus. His successor, James Merlino, previously led clinical transformation efforts at Cleveland Clinic. In turn, Ken Grubbs will become the Joint Commission's first-ever nurse to serve as chief operating officer, a symbolic and practical shift that puts frontline clinical experience closer to the organization's operational decisions.

On the insurance side, UnitedHealthcare elevated Bobby Hunter to president, where he'll lead modernization efforts including technology investments meant to simplify the member experience. Hunter wrote on LinkedIn that he hopes to build a system "where plans and providers work together more seamlessly" and "trust is earned through transparency and accountability." Those are good goals. Whether they translate into fewer denied claims and shorter wait times for patients remains to be seen. UnitedHealth Group also elevated Dan Kueter to chief commercial officer, with Brandon Cuevas, formerly of Kaiser Permanente, stepping into Kueter's old role leading UnitedHealthcare's commercial business.

Artificial intelligence is clearly shaping hiring decisions too. Optum named Ujjwal Ratan as chief AI officer for its Optum Insight unit, tasking him with building infrastructure for agentic AI tools, systems designed to act somewhat autonomously using connected data across providers, payers and pharmacy operations. Ratan described Optum's position as uniquely suited to "set the standard for agentic AI across healthcare." That's an ambitious claim, and one worth watching closely given how much patient data flows through a company that touches nearly every corner of the healthcare system.

Meanwhile, the Pharmaceutical Care Management Association, the top lobbying voice for pharmacy benefit managers, named CVS Caremark's Ed DeVaney as board chair, succeeding Express Scripts' Adam Kautzner. PBMs remain one of the most contested players in drug pricing debates, and DeVaney said he's committed to making sure policymakers understand "the work we do to fulfill our commitment to lower drug costs." Critics of the PBM model will likely view that framing skeptically, given ongoing scrutiny over how these middlemen negotiate rebates and set formularies.

Why It Matters

Leadership transitions can feel distant from everyday concerns like affording a prescription or finding a primary care appointment. But the people stepping into these roles, whether at a four-hospital regional system or a company that touches tens of millions of insured lives, will shape decisions on staffing, pricing, AI adoption and regulatory compliance for years to come. The Association of American Medical Colleges' David Skorton, who guided the group through the pandemic before his planned 2027 retirement, put it simply: leadership succession is itself a test of institutional resilience. Watching who gets chosen, and what priorities they bring, tells us a great deal about where healthcare is headed next.